- Home
- ADAP vs PLCE Comparison
ADAP vs PLCE Comparison
Compare ADAP & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- PLCE
- Stock Information
- Founded
- ADAP 2008
- PLCE 1969
- Country
- ADAP United Kingdom
- PLCE United States
- Employees
- ADAP N/A
- PLCE N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- PLCE Clothing/Shoe/Accessory Stores
- Sector
- ADAP Health Care
- PLCE Consumer Discretionary
- Exchange
- ADAP Nasdaq
- PLCE Nasdaq
- Market Cap
- ADAP 212.3M
- PLCE 174.5M
- IPO Year
- ADAP 2015
- PLCE 1997
- Fundamental
- Price
- ADAP $0.59
- PLCE $14.04
- Analyst Decision
- ADAP Strong Buy
- PLCE Hold
- Analyst Count
- ADAP 4
- PLCE 3
- Target Price
- ADAP $3.16
- PLCE $11.33
- AVG Volume (30 Days)
- ADAP 2.0M
- PLCE 338.9K
- Earning Date
- ADAP 11-13-2024
- PLCE 11-26-2024
- Dividend Yield
- ADAP N/A
- PLCE N/A
- EPS Growth
- ADAP N/A
- PLCE N/A
- EPS
- ADAP N/A
- PLCE N/A
- Revenue
- ADAP $175,041,000.00
- PLCE $1,522,802,000.00
- Revenue This Year
- ADAP $180.15
- PLCE N/A
- Revenue Next Year
- ADAP N/A
- PLCE N/A
- P/E Ratio
- ADAP N/A
- PLCE N/A
- Revenue Growth
- ADAP 146.27
- PLCE N/A
- 52 Week Low
- ADAP $0.42
- PLCE $4.77
- 52 Week High
- ADAP $2.05
- PLCE $38.03
- Technical
- Relative Strength Index (RSI)
- ADAP 26.22
- PLCE 52.79
- Support Level
- ADAP $0.75
- PLCE $12.93
- Resistance Level
- ADAP $0.83
- PLCE $16.07
- Average True Range (ATR)
- ADAP 0.07
- PLCE 1.15
- MACD
- ADAP -0.01
- PLCE 0.02
- Stochastic Oscillator
- ADAP 2.36
- PLCE 46.30
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It design, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names.